Press Releases :: BiomX, Inc. (PHGE)

May 24, 2022 1:52am EDT

BiomX Announces Corporate Restructuring

May 20, 2022 8:00am EDT

BiomX Announces Publication in the Journal, Bioinformatics

May 11, 2022 6:30am EDT

BiomX Reports First Quarter 2022 Financial Results and Provides Business Update

May 06, 2022 7:00am EDT

BiomX to Host Key Opinion Leader Event on BX004 for Treatment of Pseudomonas Aeruginosa Infections in Cystic Fibrosis Patients

May 05, 2022 8:00am EDT

BiomX to Host First Quarter 2022 Financial Results Conference Call and Webcast on May 11, 2022

Mar 30, 2022 6:30am EDT

BiomX Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

Mar 23, 2022 8:00am EDT

BiomX to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call and Webcast on March 30, 2022

Feb 24, 2022 8:00am EST

BiomX Presenting at Three Upcoming Investor Conferences

Jan 04, 2022 7:00am EST

BiomX Announces Therapeutics Development Award of up to $5 Million from the Cystic Fibrosis Foundation

Nov 17, 2021 8:00am EST

BiomX Presenting at Two Upcoming Conferences in November

Previous
1
2
3
4
5
6
7
8
9
10
Next

Investor Contact Information

Company

BiomX, Inc.
22 Einstein St.
Floor 5
Ness Ziona 7414003
Israel
info@biomx.com

Investor Relations

Anat Primovich
Corporate Project Manager
T: +972506977228
anatp@biomx.com